Lehrich Brandon M, Abiri Arash, Nguyen Theodore V, Bitner Benjamin F, Tong Charles C L, Kuan Edward C
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Medical Scientist Training Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Int Forum Allergy Rhinol. 2024 Apr;14(4):858-861. doi: 10.1002/alr.23267. Epub 2023 Sep 7.
Head and neck mucosal melanomas have a diverse mutational landscape with low mutational burden. A molecular subset (∼13%) has ROS1 mutations, which is an actionable driver mutation. ROS1-mutated patients have improved overall survival likely due to high mutational burden.
头颈部黏膜黑色素瘤具有多样化的突变图谱且突变负荷较低。一个分子亚群(约13%)存在ROS1突变,这是一种可靶向治疗的驱动突变。ROS1突变的患者总体生存率有所提高,可能是由于突变负荷较高。